HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David J Timson Selected Research

Uridine Diphosphate Galactose (UDP Galactose)

9/2016The molecular basis of galactosemia - Past, present and future.
11/2014The metastability of human UDP-galactose 4'-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor binding.
9/2013Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia.
7/2013In silico prediction of the effects of mutations in the human UDP-galactose 4'-epimerase gene: towards a predictive framework for type III galactosemia.
10/2012Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia.
10/2011In vivo and in vitro function of human UDP-galactose 4'-epimerase variants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David J Timson Research Topics

Disease

21Galactosemias (Galactosemia)
05/2021 - 04/2003
17Neoplasms (Cancer)
05/2022 - 12/2007
8Metabolic Diseases (Metabolic Disease)
02/2021 - 06/2014
6Infections
01/2020 - 12/2009
6Inborn Genetic Diseases (Disease, Hereditary)
01/2017 - 11/2003
5Cataract (Cataracts)
05/2021 - 04/2003
3Schistosomiasis (Bilharziasis)
01/2020 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2017 - 02/2008
2Breast Neoplasms (Breast Cancer)
01/2017 - 11/2009
1Muscle Spasticity (Spastic)
05/2021
1Disease Susceptibility (Diathesis)
01/2021
1Brain Diseases (Brain Disorder)
01/2021
1Hemorrhage
01/2021
1Thalassemia
03/2020
1Hemoglobinopathies
03/2020
1Trematode Infections (Fasciolopsiasis)
01/2020
1Paralysis (Palsy)
01/2020
1Tay-Sachs Disease
01/2020
1Multiple Sclerosis
07/2019
1Nervous System Diseases (Neurological Disorders)
07/2019
1Griscelli syndrome type 1
04/2019
1Snyder Robinson syndrome
04/2019
1Urinary Tract Infections (Urinary Tract Infection)
08/2018
1Pneumonia (Pneumonitis)
01/2017
1Primary Hyperoxaluria (Oxaluria, Primary)
01/2017
1Colonic Neoplasms (Colon Cancer)
01/2017
1Cattle Diseases (Bovine Diseases)
01/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2017
1Parasitic Diseases (Parasitic Disease)
01/2016
1Mevalonate Kinase Deficiency
11/2015
1Fever (Fevers)
11/2015
1African Trypanosomiasis (Nagana)
08/2012
1Dehydration (Water Stress)
11/2010
1Fructose Intolerance (Intolerance, Fructose)
04/2010

Drug/Important Bio-Agent (IBA)

17EnzymesIBA
02/2021 - 11/2003
14Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2008
12Pharmaceutical PreparationsIBA
01/2020 - 10/2010
9Galactose (Galactopyranose)FDA LinkGeneric
05/2021 - 03/2004
7GalactokinaseIBA
03/2017 - 04/2003
6NAD (NADH)IBA
08/2020 - 12/2007
6quinone (benzoquinone)IBA
08/2020 - 12/2007
6Uridine Diphosphate Galactose (UDP Galactose)IBA
09/2016 - 10/2011
5Oxidoreductases (Dehydrogenase)IBA
08/2020 - 11/2014
4Praziquantel (Biltricide)FDA Link
01/2020 - 01/2016
3LigandsIBA
05/2022 - 02/2016
3galactose-1-phosphateIBA
05/2021 - 11/2003
3Amino AcidsFDA Link
08/2020 - 01/2017
3ProdrugsIBA
08/2020 - 02/2016
3AntioxidantsIBA
08/2020 - 11/2014
3Flavin-Adenine Dinucleotide (FAD)IBA
01/2017 - 11/2014
3UDPglucose 4-Epimerase (UDP Galactose Epimerase)IBA
10/2012 - 02/2006
2Oxygen (Dioxygen)IBA
05/2022 - 03/2020
2CalciumIBA
01/2020 - 01/2018
2Dicumarol (Dicoumarol)FDA Link
01/2017 - 12/2007
2Albendazole (Albenza)FDA Link
10/2010 - 07/2010
1Hydroxyl RadicalIBA
04/2021
1CarbonIBA
04/2021
1Transaminases (Aminotransferases)IBA
01/2021
1Aldehyde Reductase (Aldose Reductase)IBA
05/2020
1Messenger RNA (mRNA)IBA
05/2020
1GlobinsIBA
03/2020
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2020
1Hemoglobins (Hemoglobin)IBA
03/2020
1Hexosaminidase A (Hex A)IBA
01/2020
1Myosins (Myosin)IBA
04/2019
1Spermine SynthaseIBA
04/2019
1ResveratrolIBA
01/2019
1SugarsIBA
12/2018
1FosfomycinFDA Link
08/2018
1Phosphotransferases (Kinase)IBA
08/2018
1Anti-Bacterial Agents (Antibiotics)IBA
08/2018
1Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA
06/2017
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2017
1UDP-N-acetylgalactosamine polypeptide N-acetylgalactosaminyltransferase 6IBA
01/2017
1Uridine Diphosphate (UDP)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Mucin-1 (CA 15-3 Antigen)IBA
01/2017
1Leucine (L-Leucine)FDA Link
01/2017
1LipopolysaccharidesIBA
01/2017
1ChemokinesIBA
01/2017
1Actins (F Actin)IBA
01/2017
1AcetylgalactosamineIBA
01/2017
1Polypeptide N-acetylgalactosaminyltransferaseIBA
01/2017
1Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA
01/2017
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017
1mevalonate kinaseIBA
11/2015
1Immunoglobulin D (IgD)IBA
11/2015
1HydrocarbonsIBA
11/2010
1benzimidazoleIBA
10/2010
1Bovine Serum AlbuminIBA
07/2010
1sulfoxideIBA
07/2010
1TriclabendazoleIBA
07/2010
1Fructose-Bisphosphate Aldolase (Aldolase)IBA
04/2010
1FructoseIBA
04/2010
1Protease Inhibitors (Protease Inhibitor)IBA
12/2009
1Laminin (Merosin)IBA
11/2009
1Superoxides (Superoxide)IBA
12/2007
1UDPglucose-Hexose-1-Phosphate Uridylyltransferase (Galactose 1 P Uridyltransferase)IBA
11/2003

Therapy/Procedure

8Therapeutics
05/2022 - 12/2007